This study firstly investigated the role and underlying mechanisms of a novel tRF3‐Thr‐AGT in regulating AP development, which broadened our knowledge in this field and provided possible diagnostic and therapeutic biomarkers for AP in clinic. This evidence concerns the gene AGT and alkaline phosphatase measurement.